BioSpace News Archive

BioMidwest

Biolog-id Joins Forces With Lifeshare Blood Center to Combat Covid-19

LifeShare Blood Center deploys Biolog-id’ s Cutting-Edge Technology Providing Digital Visibility to Convalescent Plasma Containing Antibodies from Recovered COVID-19 Patients

June 9, 2020
·
2 min read
Deals

Versant Ventures Launches Lycia Therapeutics with $50 Million

Biotechnology company Lycia Therapeutics, Inc. exited stealth mode with a $50 million commitment from founding investor Versant Ventures.

June 9, 2020
·
8 min read
Biotech Beach

Dermavant Completes Patient Enrollment for Long-Term Safety Study of Tapinarof in Adult Patients with Psoriasis

Tapinarof is a Potential First-in-Class Psoriasis Treatment with a Novel Mechanism of Action

June 9, 2020
·
5 min read
Business

CANbridge Pharmaceuticals Enters Into Rare Disease Gene Therapy Research Agreement With UMass Medical School

CANbridge Pharmaceuticals Inc. announced that it has initiated a research program with the Horae Gene Therapy Center at the UMass Medical School, in Worcester, MA, for gene therapy research in rare genetic diseases, with a focus on neuromuscular conditions.

June 9, 2020
·
4 min read
Policy

Meabco Awarded a $5.9 Million US Government Contract to Advance its BP-C2 Compound as a Medical Countermeasure for Cutaneous Radiation Injuries

Award from the National Institute of Allergy and Infectious Diseases (NIAID) Radiation and Nuclear Countermeasures Program

June 9, 2020
·
2 min read
Deals

DNAnexus Completes $100 Million Financing

Supporting the company’s global biomedical data and informatics platform and expansion in clinical diagnostics, pharmaceuticals, and medical centers

June 9, 2020
·
3 min read
Bio NC

BioAgilytix Launches Customizable Testing Packages Supporting Solutions to Treat and Prevent Spread of COVID-19

The CRO has applied its clinical assay and diagnostics capabilities to address a breadth of sponsor and employer needs stemming from the COVID-19 pandemic

June 9, 2020
·
4 min read
Biotech Bay

Cortexyme Announces “Atuzaginstat” Selected as First-in-Class Nonproprietary Name for COR388

Cortexyme, Inc. announced that the International Nonproprietary Naming Committee of the World Health Organization has selected atuzaginstat as the proposed International Nonproprietary Name, or pINN, for the company’s lead product candidate COR388.

June 9, 2020
·
3 min read
Policy

Veracyte Announces De Novo Classification Request to FDA for the nCounter Dx LymphMark Assay

Veracyte, Inc. announced its submission of a De Novo classification request to the U.S. Food & Drug Administration for the nCounter® Dx LymphMark™ Assay, a novel, genomic lymphoma subtyping test.

June 9, 2020
·
5 min read
Biotech Bay

Marrone Bio Innovations and UPL Sign Exclusive Distribution Agreement for REGALIA® MAXX in the Republic of South Africa

Marrone Bio Innovations, Inc., an international leader in sustainable bioprotection and plant health solutions, announced the signing of an exclusive commercial agreement with UPL to distribute REGALIA® MAXX Fungicide in the Republic of South Africa.

June 9, 2020
·
4 min read